A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma
NCT ID: NCT02482909
Last Updated: 2015-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
68 participants
INTERVENTIONAL
2005-07-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma With Twin Cooled-wet Electrodes
NCT05449860
RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode
NCT02806076
Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma
NCT05580224
No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet Electrodes
NCT05449873
Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC
NCT02535117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hepatic resection
Hepatic resection is performed as a primary treatment for hepatocellular carcinoma.
Hepatic resection
Anatomical surgical resection of the liver including the tumor
Radiofrequency ablation
Radiofrequency ablation is performed as a primary treatment for hepatocellular carcinoma.
Radiofrequency ablation
Percutaneous ablation using radiofrequency under the imaging guidance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hepatic resection
Anatomical surgical resection of the liver including the tumor
Radiofrequency ablation
Percutaneous ablation using radiofrequency under the imaging guidance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Child-Pugh class A (score 5-6)
3. Single hepatocellular carcinoma
4. Maximal diameter of the tumor from 2 to 4 cm when measured on MRI or CT (The diameter on MRI was measured prior to that on CT)
5. No previous treatment
6. Platelet count \> 80,000/mm3
Exclusion Criteria
2. HCC abutting vessels ≥ 0.5 cm
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Center, Korea
OTHER_GOV
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kyung-Suk Suh
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kyung-Suk Suh, ME, PhD
Role: STUDY_DIRECTOR
Seoul National University Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0520090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.